Physician Resources, LLC

10/27/2025

What’s top of mind for our team this month.

Pharma Industry Perceptions Take a Hit
Gen Z and Millennials show sharply dropping rates of satisfaction with the pharmaceutical industry and perceived value, a YouGov report shows. Ratings by older generations remain steady.

EADV Updates
A slate of new data came from the 2025 EADV Congress, including remarkable efficacy findings from the Phase 3 studies of icotrokinra, the oral peptide that selectively blocks the IL-23 receptor.

Adherence as Habit
Grappling with patient adherence recommendations? New data show that habit is more important than conscious choice in driving behavior. Two-thirds of daily behaviors are made “on autopilot,” according to a study in Psychology & Health.

HCP Market Tightens
The HCP market in the US is tight. Physicians accepted 71% of offers in 2024 (83% in 2023), while APPs accepted 80% (71% in 2023), reports the Association for Advancing Physician and Provider Recruitment (AAPPR).

FDA Actions
Tremfya® (guselkumab, Johnson & Johnson): Approved for moderate to severe PsO or active PsA in children 6+.
Opzelura (ruxolitinib, Incyte): First topical JAKi approved in US for pediatric AD.
Rhapsido® (remibrutinib, Novartis): Oral BTKi, is now approved for adult CSU.
Zoryve® (roflumilast, Arcutis) cream 0.05%: Mild to moderate AD in children aged 2–5.

10/03/2025

We love celebrating our fall birthdays at Physician Resources! Our own Elisa Damato on Sept 16 and Paul Winnington on Oct 3! They are our own “married” work couple who absolutely enjoy fussing at each other! We wouldn’t have it any other way 😍

09/05/2025

5 Things We’re Tracking in Derm This Month

Alopecia Updates
Leqselvi™ (deuruxolitinib) is now available in the US for severe alopecia areata.
Rinvoq® (upadacitinib) shows strong results in Phase 3 trials for AA.

Mousse Sunscreens = FDA Trouble
The FDA has warned brands: mousse and foam sunscreens are not yet approved dosage forms. They’ll need new OTC drug approvals to stay on the market.

OX40 Treatment on the Horizon?
Atopic dermatitis treatment dosed just 4x a year may become a reality based on phase 3 study results for Sanofi's OX40-ligand agent, amlitelimab.

FDA Updates
Anzupgo® cream approved for chronic hand eczema, first of its kind.
Otezla gets green light to treat PsA in kids 6+.

Skincare > Surgery?
OTC skincare is booming. Dr. Chilukuri says Kris Jenner’s glow at 69 isn’t just surgery—it’s great skincare and energy-based treatments.

Follow us for more dermatology news

08/21/2025

We’re excited to share that Physician Resources, LLC has received Honorable Mention in .group Magazine’s 22nd Annual Corporate Event Awards for our work creating and producing the DERM2024 NP/PA CME Conference—the largest national CME event for NPs and PAs in dermatology.

This award recognizes excellence in event-marketing strategy and ex*****on, and celebrates the detailed work behind the scenes: from agenda development and fundraising to branding, social media, and onsite experience.

DERM2024 was created by Physician Resources to build on the Marvel®-inspired theme: “Dermatology heroes aren’t born…they’re trained.” For us, that message shaped every part of the meeting—from session topics and signage to faculty messaging and digital media.

We’re proud to support the amazing faculty and exceptional sponsors who work with and support the Dermatology Education Foundation () and grateful to our entire team and partners who help us raise the bar each year.

07/19/2025

All of our coworkers get involved in prepping materials for as we head to Las Vegas to ! Sadly, Zeus can’t participate this year

06/14/2025

Happy Birthday to our incredible CEO, Stacey Moore!

Stacey, thank you for your commitment, your clarity, and your ability to lead with both purpose and heart. Happy Birthday from all of us at Physician Resources! 🎂🥳

06/06/2025

We've got more effective drugs than ever before to treat a wide range of diseases. But what good are these treatments if patients can't get them? Educating prescribers about issues related to patient access has been an increasingly important part of the programming we develop at Physician Resources. New survey data shows we are in sync with prescribers. A surveyed sample of physicians, NPs, and PAs--including those in dermatology--recently said that they need pharmaceutical companies to provide educational support (43%) and resources related to insurance coverage and financial support (39%). Healthcare in the US continues to evolve, but high drug development costs, the influence of PBMs, and the use of prior authorizations are here for the foreseeable future. At PR, we recognize that prescribers need to understand not only how newer treatments work but also how to get them into patients' hands.

05/11/2025

Happy Mother's Day to all the Moms! Today’s for you—and so is every other day, honestly. 💐💖

03/19/2025

Physician Resources is proud to have produced the latest DEF Biologic & Small Molecule CME Bootcamp in Dallas this weekend. This program has continuously evolved over the years, and every Bootcamp has been different from the ones before. This year, we are excited to innovate once again with a first-ever educational theme for the bootcamp series. Our expert faculty often discusses the "sorting hat" of therapeutic selection. We went all in on this apt analogy to implement a Harry Potter inspired theme that carried through from the educational slides and handouts to the decor and food service. Our attendees were able to interact during engaging "house" challenges, and they left the event feeling like they truly had "mastered the magic of treatment selection" for inflammatory skin diseases.

03/11/2025

Physician Resources proudly congratulates Susan C. Taylor, MD, FAAD, as she begins her term as President of the American Academy of Dermatology. Dr. Taylor is the first African American dermatologist and sixth woman to hold this prestigious role.

A leader in dermatology, Dr. Taylor has dedicated her career to advancing patient care, education, and advocacy. We’ve had the privilege of working with her for more than two decades on scientific poster presentations and articles, advisory boards, symposia and more; it is always a pleasure! She is more than well suited to address the needs of the dermatologist.

We wish her success as she leads the AAD in tackling key challenges, from improving access to care to supporting dermatology professionals through advocacy and education. Congratulations, Dr. Taylor! 👏

03/08/2025

Live from AAD! Filming, learning, and catching up with the best.

03/05/2025

In our recent blog post, we break down new research showing that 65.8% of adults don’t trust AI to be used responsibly in healthcare. Trust isn’t about how much patients know about AI. It depends on how much they trust the system using it

As AI becomes more common in healthcare, building trust through clear communication and responsible use is essential. Read more in our latest blog.

Do Patients Trust Healthcare Systems to Use AI Safely? by PR Blog | Feb 21, 2025 | Uncategorized As use of artificial intelligence (AI) becomes increasingly more mainstream, new research shows that patients have reservations about its use in healthcare. In fact, nearly two-thirds of adults surveyed....